Search publications
42 results found
Active filters:
-
Collaboration between three hospitals benefits cancer patients
Three hospitals in the central Dutch province of Utrecht are allowed to collaborate in complex cancer care. The Netherlands Authority for Consumers and Markets (ACM) expects this collaboration to yield sufficient benefits for patients and the insured. The … -
ACM Working Paper: Reconciling competition and IP law: the case of patented pharmaceuticals and dominance abuse
Chris Fonteijn, Ilan Akker and Wolf Sauter have written a scientific publication for the book on competition law and intellectual property law to be published later in 2018. The title of their contribution is 'Reconciling competition and IP law: the case … -
Lower drug prices do not necessarily stand in the way of innovation
The minister must use the gains for society as the guiding factor when neogtiating drug prices Lowering the prices of expensive, innovative prescription drugs can actually boost the incentives to innovate. This view contrasts sharply with the current … -
ACM: room for collaboration involving the distribution of essential drugs for COVID-19 patients
Hospitals, hospital pharmacies, and pharmaceutical wholesalers are allowed to collaborate closely with each other during the current coronavirus (COVID-19) outbreak in order to prevent or reduce any shortages of essential drugs. To that end, the National … -
ACM studies: the insured’s diversity of wishes affects the negotiation balance between health insurers and hospitals
Approximately one in three insured believe that health insurers should negotiate fiercely in order to keep premiums low. Almost the same percentage of insured believe that health insurers should predominantly offer unlimited choice in health care options. … -
ACM closes investigation into drug manufacturer AbbVie, competitors get more room now
Drug manufacturer AbbVie has stated that it will not force hospitals to purchase exclusively or to a large extent from AbbVie through discount schemes (or rebate programs). AbbVie has made these assurances following an investigation conducted by the … -
Dutch health insurers may distribute the additional costs of effects of the coronavirus crisis among each other
This year, Dutch health insurers may distribute the additional costs of the effects of the coronavirus (COVID-19) crisis among themselves. The Netherlands Authority for Consumers and Markets has come to this conclusion following questions posed by health … -
ACM’s response to the health insurers’ agreement on the distribution of the costs of the COVID-19 crisis for 2020
For 2020, Dutch health insurers are allowed to distribute the additional costs of the effects of the coronavirus (COVID-19) crisis among themselves. The Netherlands Authority for Consumers and Markets has come to this conclusion following questions posed … -
Erasmus University Medical Center and IJsselland Hospital withdraw application for acquisition license
Erasmus University Medical Center (Erasmus MC) in the city of Rotterdam will not acquire IJsselland Hospital located in the town of Capelle aan den IJssel. The hospitals have informed the Netherlands Authority for Consumers and Markets (ACM) of this … -
ACM to draw up guidelines regarding competition rules in order to mitigate ‘vendor lock-in’ in health care IT
The Netherlands Authority for Consumers and Markets (ACM) will draw up guidelines that will clarify the competition rules for IT suppliers in health care. ACM has found that, in many cases, hospitals are ‘locked-in’ with their suppliers of health …